Covaxin gets emergency use approval for kids aged 2-18 years
0 Comments

In a significant development, Bharat Biotech’s COVID-19 vaccine, Covaxin got DGCI’s approval on Tuesday for usage on kids aged 2-18.

This came after Hyderabad-based Bharat Biotech had completed Phase-2 and Phase-3 trials of Covaxin in September on children below 18 years of age. The company had submitted the trial data to the Drugs and Comptroller General of India (DCGI) earlier this month.

The drug regulator said, “After detailed deliberation, the committee recommended for grant of market authorization” to children in age group of 2-18 years.

Covaxin gets emergency use approval for kids aged 2-18 years

Bharat Biotech’s Covaxin gets emergency approval for kids aged 2-18 years

Covaxin: Expert panel recommends emergency use approval for 2-18 year olds

BIG BREAKING: DCGI approves Covaxin for kids in 2-18 age group

Covaxin gets emergency use nod for children aged 2-18 years

Covaxin gets approval for children between 2-18 years

 

 

 

 

Author

rakesh.manzi@gmail.com

Leave a Reply

Your email address will not be published. Required fields are marked *